Victory Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.05M Buy
5,836
+14
+0.2% +$6.69K ﹤0.01% 1486
2025
Q4
$3.39M Buy
5,822
+59
+1% +$30.1K ﹤0.01% 1443
2025
Q3
$2.64M Sell
5,763
-2,518
-30% -$939K ﹤0.01% 1531
2025
Q2
$2.51M Sell
8,281
-60,109
-88% -$17.9M ﹤0.01% 1526
2025
Q1
$22.7M Sell
68,390
-2,245
-3% -$738K 0.02% 768
2024
Q4
$21.8M Buy
70,635
+68,343
+2,982% +$19.2M 0.02% 811
2024
Q3
$486K Buy
2,292
+40
+2% +$10.2K ﹤0.01% 2009
2024
Q2
$631K Buy
2,252
+124
+6% +$29.5K ﹤0.01% 1904
2024
Q1
$568K Buy
2,128
+208
+11% +$49K ﹤0.01% 1941
2023
Q4
$444K Buy
1,920
+499
+35% +$87.3K ﹤0.01% 2027
2023
Q3
$208K Sell
1,421
-1,293
-48% -$243K ﹤0.01% 2196
2023
Q2
$627K Sell
2,714
-159
-6% -$43.1K ﹤0.01% 1892
2023
Q1
$696K Buy
2,873
+1,475
+106% +$402K ﹤0.01% 1873
2022
Q4
$406K Buy
+1,398
New +$137K ﹤0.01% 2075
2020
Q2
Sell
-3,302
Closed -$220K 2948
2020
Q1
$220K Buy
3,302
+1,477
+81% +$123K ﹤0.01% 2303
2019
Q4
$166K Buy
1,825
+354
+24% +$34.3K ﹤0.01% 2365
2019
Q3
$127K Buy
+1,471
New +$138K ﹤0.01% 2364
2019
Q2
Sell
-19,885
Closed -$2.49M 1850
2019
Q1
$2.49M Buy
19,885
+6,870
+53% +$854K 0.01% 1044
2018
Q4
$1.47M Sell
13,015
-180,683
-93% -$28M ﹤0.01% 1113
2018
Q3
$41.5M Buy
193,698
+9,451
+5% +$2.37M 0.09% 396
2018
Q2
$51.5M Sell
184,247
-18,735
-9% -$3.29M 0.11% 293
2018
Q1
$23.7M Sell
202,982
-1,224
-0.6% -$151K 0.05% 545
2017
Q4
$18.7M Buy
204,206
+153,650
+304% +$8.78M 0.04% 595
2017
Q3
$2.27M Buy
+50,556
New +$946K 0.01% 950

Other funds holding MDGL